A STUDY published in the US
this week has found that
hydrochlorothiazide is much less
effective than other blood pressure
drugs, and could give hypertension
patients a “false sense of security”.
Researchers at the St Luke’s-
Roosevelt Hospital in New York
reviewed previous studies and
found that thiazides lowered blood
pressure by only about half as
much as beta blockers and ACE
In the 19 studies reviewed, low
doses of hydrochlorothiazide
reduced systolic blood pressure by
6.5 points on average, compared to
11.2 points for beta blcokers, 11
points for calcium channel blockers,
and ACE inhibitors by 12.9 points.
Lead scientist Franz Messerli said
the results showed that
hydrochlorothiazide should not be
used alone to lower blood pressure.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 11
from the fields Pharmaceutical (FTFP) is unveiling an information drive targeting community pharmacy, ahead of the 01 Mar commencement of new retail regulations for the sale and distribution of medically prescribed vaping products in pharmacies.